Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Setanaxib |
| Synonyms | |
| Therapy Description |
Setanaxib (GKT137831) inhibits NADPH oxidase isoform 1 (NOX1) and isoform 4 (NOX4) (PMID: 20942471), and may potentially alter reactive oxygen species levels and decrease tumor cell growth (PMID: 35326163). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Setanaxib | GKT137831 | Setanaxib (GKT137831) inhibits NADPH oxidase isoform 1 (NOX1) and isoform 4 (NOX4) (PMID: 20942471), and may potentially alter reactive oxygen species levels and decrease tumor cell growth (PMID: 35326163). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|